Why are European healthcare costs so much lower — and innovation so much slower? This talk dives into cultural and structural contrasts: lean European organizations vs. U.S. executive roles, risk-averse workforces, conservative investors, and heavy regulation. With a focus on Germany–U.S. contracts, we’ll explore what it really takes to break into transatlantic healthcare markets.
The Bench2Market Talks series is created to provide commercialization guidance to the university research community. For more details on the series, visit our website at www.biolocity.gatech.edu/bench2market.
Powered by WordPress & Theme by Anders Norén
You must be logged in to post a comment.